Australia markets closed

BELLUS Health Inc. (BLU)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.75-0.22 (-3.69%)
At close: 04:00PM EST
5.60 -0.15 (-2.61%)
After hours: 05:18PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 462.89M
Enterprise value 404.93M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)27.66k
Price/book (mrq)4.83
Enterprise value/revenue 25.31k
Enterprise value/EBITDA -6.36

Trading information

Stock price history

Beta (5Y monthly) -0.68
52-week change 3101.01%
S&P500 52-week change 324.55%
52-week high 37.65
52-week low 32.60
50-day moving average 36.35
200-day moving average 34.38

Share statistics

Avg vol (3-month) 32.52M
Avg vol (10-day) 31.08M
Shares outstanding 578.34M
Implied shares outstanding 6N/A
Float 855.26M
% held by insiders 19.41%
% held by institutions 173.39%
Shares short (14 Nov 2021) 44.06M
Short ratio (14 Nov 2021) 43.83
Short % of float (14 Nov 2021) 4N/A
Short % of shares outstanding (14 Nov 2021) 45.18%
Shares short (prior month 14 Oct 2021) 43.02M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Aug 2019
Ex-dividend date 4N/A
Last split factor 2277:1000
Last split date 318 Aug 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-405,487.50%

Management effectiveness

Return on assets (ttm)-34.25%
Return on equity (ttm)-60.50%

Income statement

Revenue (ttm)16k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)33.30%
Gross profit (ttm)15k
EBITDA N/A
Net income avi to common (ttm)-63.95M
Diluted EPS (ttm)-0.85
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)58.35M
Total cash per share (mrq)0.75
Total debt (mrq)394k
Total debt/equity (mrq)0.41
Current ratio (mrq)3.42
Book value per share (mrq)1.22

Cash flow statement

Operating cash flow (ttm)-49.47M
Levered free cash flow (ttm)-23.81M